Safety and Efficacy Study of a Hydrogel, Applied Following Removal of Myomas During Gynecologic Surgery, Administered for the Prevention/Reduction of Postoperative Adhesion Formation

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

76

Participants

Timeline

Start Date

July 31, 2003

Study Completion Date

January 31, 2005

Conditions
Myoma
Interventions
OTHER

Adhibit Adhesion Prevention Gel

A resorbable hydrogel, which adheres to itself and the tissues it contacts, is approved for use in sealing vascular reconstructions. The hydrogel is formed when two synthetic derivatized polyethylene glycol (PEG) polymers are mixed together and applied to tissue. Using a gas-assisted delivery device, the hydrogel is sprayed over all myomectomy suture lines and all surgically treated areas during the myomectomy surgery. The hydrogel is totally resorbed within 30 days post-application.

OTHER

Standard of Care Comparator

standard of care for post-operative adhesion prevention included irrigation of tissues and lavage of all fluids with Ringers Lactate solution following surgery and 300 to 500mL of solultion left in the pelvic cavity immediately prior to wound closure

Trial Locations (6)

14129

Klinik für Minimal Invasive Chirurgie, Berlin

24105

Univ. Clinics of Schleswig-Holstein, Kiel

42109

Bethesda Krankenhaus Wupperta, Wuppertal

M6R 3B2

St. Joseph's Health Centre, Toronto

D-35385

Universitätsklinikum Giessen, Giessen

Unknown

St. Elizabeth Hospital, Curaçao

Sponsors
All Listed Sponsors
lead

Angiotech Pharmaceuticals

INDUSTRY

NCT00562471 - Safety and Efficacy Study of a Hydrogel, Applied Following Removal of Myomas During Gynecologic Surgery, Administered for the Prevention/Reduction of Postoperative Adhesion Formation | Biotech Hunter | Biotech Hunter